{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:43:26Z","timestamp":1785408206450,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Left-side portal hypertension (LSPH) is caused by isolated obstruction of the splenic vein and is associated with esophagogastric varices that extend from the lower esophagus to the greater curvature of the gastric body. Here, we report on a 74-year-old man with a pancreatic neuroendocrine neoplasm (NEN) in the pancreatic tail with multiple liver metastases. We decided that partial splenic embolization (PSE) was the best course of treatment to prevent rupture of the gastric varices, which were classified as markedly enlarged, nodular, or tumor-shaped and showed erosion of the mucosa. After PSE, the patient had no major complications and was discharged. At 3 and 6\u00a0months after the procedure, esophagogastroduodenoscopy and enhanced computerized tomography showed that the gastric varices had improved. This case demonstrates the usefulness of PSE for LSPH in patients with unresected pancreatic NEN.<\/jats:p>","DOI":"10.1007\/s12328-022-01631-7","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T20:03:02Z","timestamp":1650139382000},"page":"796-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-2739","authenticated-orcid":false,"given":"Teppei","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenari","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Amanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Mukozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"1631_CR1","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/cncr.23432","volume":"112","author":"CR Kauffman","year":"2008","unstructured":"Kauffman CR, Mahvash A, Kopetz S, et al. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer. 2008;112:2283\u20138.","journal-title":"Cancer"},{"key":"1631_CR2","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.3748\/wjg.v18.i24.3138","volume":"18","author":"XH He","year":"2012","unstructured":"He XH, Gu JJ, Li WT, et al. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism. World J Gastroenterol. 2012;18:3138\u201344.","journal-title":"World J Gastroenterol"},{"key":"1631_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2214\/AJR.10.4401","volume":"195","author":"CF Gonsalves","year":"2010","unstructured":"Gonsalves CF, Mitchell EP, Brown DB. Management of hypersplenism by partial splenic embolization with ethylene vinyl alcohol copolymer. AJR Am J Roentgenol. 2010;195:1241\u20134.","journal-title":"AJR Am J Roentgenol"},{"key":"1631_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1399-0012.2009.01081.x","volume":"24","author":"R Barcena","year":"2010","unstructured":"Barcena R, Moreno A, Foruny JR, et al. Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome. Clin Transplant. 2010;24:366\u201374.","journal-title":"Clin Transplant"},{"key":"1631_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/lt.22280","volume":"17","author":"C Quintini","year":"2011","unstructured":"Quintini C, D\u2019Amico G, Brown C, et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl. 2011;17:668\u201373.","journal-title":"Liver Transpl"},{"key":"1631_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/lt.20543","volume":"11","author":"HY Ou","year":"2005","unstructured":"Ou HY, Huang TL, Chen TY, et al. Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left-sided portal hypertension. Liver Transpl. 2005;11:1136\u20139.","journal-title":"Liver Transpl"},{"key":"1631_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1259\/0007-1285-68-812-928","volume":"68","author":"VG Mc Dermott","year":"1995","unstructured":"Mc Dermott VG, England RE, Newman GE. Case report: bleeding gastric varices secondary to splenic vein thrombosis successfully treated by splenic artery embolization. Br J Radiol. 1995;68:928\u201330.","journal-title":"Br J Radiol"},{"key":"1631_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000329888","volume":"21","author":"L Wang","year":"2012","unstructured":"Wang L, Liu GJ, Chen YX, et al. Sinistral portal hypertension: clinical features and surgical treatment of chronic splenic vein occlusion. Med Princ Pract. 2012;21:20\u20133.","journal-title":"Med Princ Pract"},{"key":"1631_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3349\/ymj.2012.53.5.944","volume":"53","author":"TG Oh","year":"2012","unstructured":"Oh TG, Chung MJ, Park JY, et al. Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experience. Yonsei Med J. 2012;53:944\u201351.","journal-title":"Yonsei Med J"},{"key":"1631_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1677\/ERC-08-0017","volume":"15","author":"UF Pape","year":"2008","unstructured":"Pape UF, Berndt U, M\u00fcller-Nordhorn J, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer. 2008;15:1083\u201397.","journal-title":"Endocr Relat Cancer"},{"key":"1631_CR11","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.1158\/1078-0432.CCR-08-0734","volume":"14","author":"S Ekeblad","year":"2008","unstructured":"Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798\u2013803.","journal-title":"Clin Cancer Res"},{"key":"1631_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000197899","volume":"89","author":"J Strosberg","year":"2009","unstructured":"Strosberg J, Gardner N, Kvols L. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the midgut. Neuroendocrinology. 2009;89:471\u20136.","journal-title":"Neuroendocrinology"},{"key":"1631_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumors with liver metastases: results of the UKINETS study. Endocr Relat Cancer. 2009;16:885\u201394.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1631_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000287277","volume":"91","author":"M Pavel","year":"2010","unstructured":"Pavel M, Grossman A, Arnold R, et al. ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors. Neuroendocrinology. 2010;91(4):326\u201332.","journal-title":"Neuroendocrinology"},{"key":"1631_CR15","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years \u2018after carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"1631_CR16","first-page":"758","volume":"56","author":"GR Evans","year":"1990","unstructured":"Evans GR, Yellin AE, Weaver FA, et al. Sinistral (left-sided) portal hypertension. Am Surg. 1990;56:758\u201363.","journal-title":"Am Surg"},{"issue":"79","key":"1631_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0002-9610(00)00250-6","volume":"1","author":"GH Sakorafas","year":"2000","unstructured":"Sakorafas GH, Sarr MG, Farley DR, et al. The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg. 2000;1(79):129\u201333.","journal-title":"Am J Surg"},{"key":"1631_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s10620-005-2674-x","volume":"50","author":"S K\u00f6kl\u00fc","year":"2005","unstructured":"K\u00f6kl\u00fc S, Y\u00fcksel O, Arhan M, et al. Report of 24 left-sided portal hypertension cases: a single-center prospective cohort study. Dig Dis Sci. 2005;50:976\u201382.","journal-title":"Dig Dis Sci"},{"key":"1631_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10620-006-9307-x","volume":"52","author":"S K\u00f6kl\u00fc","year":"2007","unstructured":"K\u00f6kl\u00fc S, Coban S, Y\u00fcksel O, et al. Left-sided portal hypertension. Dig Dis Sci. 2007;52:1141\u20139.","journal-title":"Dig Dis Sci"},{"key":"1631_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00000658-198607000-00010","volume":"204","author":"MS Madsen","year":"1986","unstructured":"Madsen MS, Petersen TH, Sommer H. Segmental portal hypertension. Ann Surg. 1986;204:72\u20137.","journal-title":"Ann Surg"},{"key":"1631_CR21","volume-title":"Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN)","author":"Japan Neuroendocrine Tumor Society (JNETS)","year":"2019","unstructured":"Japan Neuroendocrine Tumor Society (JNETS). Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). 2nd ed. JNETS; 2019.","edition":"2"},{"issue":"6","key":"1631_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1477-7819-6-80","volume":"28","author":"DL Joyce","year":"2008","unstructured":"Joyce DL, Hong K, Fishman EK, et al. Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension. World J Surg Oncol. 2008;28(6):80.","journal-title":"World J Surg Oncol"},{"key":"1631_CR23","first-page":"1326","volume":"7","author":"M Olakowski","year":"2001","unstructured":"Olakowski M, Lampe P, Bo\u0142dys H, et al. Neuroendocrine pancreatic carcinoma causing sinistral portal hypertension. Med Sci Monit. 2001;7:1326\u20138.","journal-title":"Med Sci Monit"},{"key":"1631_CR24","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/j.ijscr.2021.105724","volume":"81","author":"S Kumar","year":"2021","unstructured":"Kumar S, Raobiakady R, Watkins D, et al. Radical resection of large metastatic non-functional pancreatic neuroendocrine carcinoma complicated by splenic vein thrombosis and sinistral portal hypertension. Int J Surg Case Rep. 2021;81:105724.","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"1631_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/pancan.2017.0017","volume":"3","author":"TN Moyana","year":"2017","unstructured":"Moyana TN, Macdonald DB, Martel G, et al. Pancreatic neuroendocrine tumors complicated by sinistral portal hypertension: insights into pathogenesis. J Pancreat Cancer. 2017;3(1):71\u20137.","journal-title":"J Pancreat Cancer"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-022-01631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:56:58Z","timestamp":1659016618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-022-01631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1007\/s12328-022-01631-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedure followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"This study does not contain identifying information of the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}